InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 10/3046% below fair value
$0.77−0.03 (-3.25%)
Close on Nov 12, 2026Market cap $35.98MP/E –Yield –
InspireMD operating margin
Operating margin is operating income as a percentage of revenue.
InspireMD's operating margin for the twelve months ending Jun 30, 2026 was -494.0%. For fiscal 2025 it was -552.6%, against -478.0% the year before. The highest annual figure on record is -65.0% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -552.6% | −74.6 |
| FY2024 | Dec 31, 2024 | -478.0% | −137.3 |
| FY2023 | Dec 31, 2023 | -340.7% | +21.1 |
| FY2022 | Dec 31, 2022 | -361.9% | −34.5 |
| FY2021 | Dec 31, 2021 | -327.4% | +90.3 |
| FY2020 | Dec 31, 2020 | -417.7% | −153.9 |
| FY2019 | Dec 31, 2019 | -263.8% | −52.4 |
| FY2018 | Dec 31, 2018 | -211.4% | +86.8 |
| FY2017 | Dec 31, 2017 | -298.2% | +105.6 |
| FY2016 | Dec 31, 2016 | -403.8% | +223.3 |
| FY2015 | Dec 31, 2015 | -627.1% | −317.7 |
| FY2013 | Jun 30, 2013 | -309.3% | −244.3 |
| FY2010 | Dec 31, 2010 | -65.0% | +14.6 |
| FY2009 | Dec 31, 2009 | -79.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -815.6% | −83.4 |
| Q1 FY2026 | Mar 31, 2026 | -411.4% | +338.1 |
| Q4 FY2025 | Dec 31, 2025 | -383.7% | +96.9 |
| Q3 FY2025 | Sep 30, 2025 | -517.3% | −49.8 |
| Q2 FY2025 | Jun 30, 2025 | -732.2% | −257.2 |
| Q1 FY2025 | Mar 31, 2025 | -749.5% | −258.8 |
| Q4 FY2024 | Dec 31, 2024 | -480.6% | −150.8 |
| Q3 FY2024 | Sep 30, 2024 | -467.5% | −105.1 |
| Q2 FY2024 | Jun 30, 2024 | -475.0% | −152.7 |
| Q1 FY2024 | Mar 31, 2024 | -490.7% | −137.1 |
| Q4 FY2023 | Dec 31, 2023 | -329.8% | +151.3 |
| Q3 FY2023 | Sep 30, 2023 | -362.4% | −40.3 |
| Q2 FY2023 | Jun 30, 2023 | -322.3% | −16.6 |
| Q1 FY2023 | Mar 31, 2023 | -353.6% | +25.6 |
| Q4 FY2022 | Dec 31, 2022 | -481.1% | −196.2 |
| Q3 FY2022 | Sep 30, 2022 | -322.2% | +54.2 |
| Q2 FY2022 | Jun 30, 2022 | -305.7% | +25.7 |
| Q1 FY2022 | Mar 31, 2022 | -379.2% | −49.8 |
| Q4 FY2021 | Dec 31, 2021 | -284.9% | +2068.3 |
| Q3 FY2021 | Sep 30, 2021 | -376.4% | −152.4 |
| Q2 FY2021 | Jun 30, 2021 | -331.4% | +450.1 |
| Q1 FY2021 | Mar 31, 2021 | -329.4% | −134.0 |
| Q4 FY2020 | Dec 31, 2020 | -2353.2% | −2105.8 |
| Q3 FY2020 | Sep 30, 2020 | -224.0% | −11.3 |
| Q2 FY2020 | Jun 30, 2020 | -781.5% | −620.2 |
| Q1 FY2020 | Mar 31, 2020 | -195.5% | +558.8 |
| Q4 FY2019 | Dec 31, 2019 | -247.4% | +21.0 |
| Q3 FY2019 | Sep 30, 2019 | -212.7% | +44.7 |
| Q2 FY2019 | Jun 30, 2019 | -161.2% | −14.4 |
| Q1 FY2019 | Mar 31, 2019 | -754.2% | −560.3 |
| Q4 FY2018 | Dec 31, 2018 | -268.4% | −94.6 |
| Q3 FY2018 | Sep 30, 2018 | -257.3% | +33.0 |
| Q2 FY2018 | Jun 30, 2018 | -146.9% | +211.6 |
| Q1 FY2018 | Mar 31, 2018 | -193.9% | +228.6 |
| Q4 FY2017 | Dec 31, 2017 | -173.7% | +476.6 |
| Q3 FY2017 | Sep 30, 2017 | -290.4% | +84.5 |
| Q2 FY2017 | Jun 30, 2017 | -358.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -422.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -650.3% | – |
| Q3 FY2016 | Sep 30, 2016 | -374.8% | – |
See a number that looks wrong?